Efficacy and safety of chinese herbal medicine for treating mild or moderate COVID-19: A systematic review and meta-analysis of randomized controlled trials and observational studies
Background: The coronavirus disease 2019 (COVID-19) is still a pandemic globally, about 80% of patients infected with COVID-19 were mild and moderate. Chinese herbal medicine (CHM) has played a positive role in the treatment of COVID-19, with a certain number of primary studies focused on CHM in man...
Saved in:
Main Authors: | Hongfei Zhu (Author), Mengting Li (Author), Chen Tian (Author), Honghao Lai (Author), Yuqing Zhang (Author), Jiaheng Shi (Author), Nannan Shi (Author), Hui Zhao (Author), Kehu Yang (Author), Hongcai Shang (Author), Xin Sun (Author), Jie Liu (Author), Long Ge (Author), Luqi Huang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies
by: Mengting Li, et al.
Published: (2022) -
Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis
by: Qi Wang, et al.
Published: (2021) -
Association of soft drinks and 100% fruit juice consumption with risk of cancer: a systematic review and dose-response meta-analysis of prospective cohort studies
by: Bei Pan, et al.
Published: (2023) -
Reporting quality of acupuncture overviews: A methodological investigation based on the PRIOR statement
by: Tingting Lu, et al.
Published: (2024) -
Mbd2 Mediates Retinal Cell Apoptosis by Targeting the lncRNA Mbd2-AL1/miR-188-3p/Traf3 Axis in Ischemia/Reperfusion Injury
by: Yanni Ge, et al.
Published: (2020)